Motivations of children and their parents to participate in drug research: a systematic review

被引:49
作者
Tromp, Krista [1 ]
Zwaan, C. Michel [2 ]
van de Vathorst, Suzanne [1 ]
机构
[1] Erasmus MC, Dept Med Eth & Philosophy Med, POB 2040, NL-3000 CA Rotterdam, Netherlands
[2] Erasmus MC, Sophia Childrens Hosp, Dept Pediat Oncol Hematol, POB 2040, NL-3000 CA Rotterdam, Netherlands
关键词
Clinical drug research; Child; Parents; Motivations; Participation; Ethics; CLINICAL-RESEARCH; INFORMED-CONSENT; DECISION-MAKING; PEDIATRIC RESEARCH; CANCER; ADOLESCENTS; EXPERIENCES; ATTITUDES; BARRIERS; ONCOLOGY;
D O I
10.1007/s00431-016-2715-9
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Information on motivations for research participation, may enable professionals to better tailor the process of recruitment and informed consent to the perspective of parents and children. Therefore, this systematic review assesses motivating and discouraging factors for children and their parents to decide to participate in clinical drug research. Studies were identified from searches in 6 databases. Two independent reviewers screened and selected relevant articles. Results were aggregated and presented by use of qualitative metasummary. 38 studies fulfilled the selection criteria and were of sufficient quality for inclusion in the qualitative metasummary. Most mentioned motivating factors for parents were: health benefit for child, altruism, trust in research, and relation to researcher. Most mentioned motivating factors for children were: personal health benefit, altruism and increasing comfort. Fear of risks, distrust in research, logistical aspects and disruption of daily life were mentioned most by parents as discouraging factors. Burden and disruption of daily life, feeling like a "guinea pig" and fear of risks were most mentioned as discouraging factors by children. Conclusion: Paying attention to these motivating and discouraging factors of children and their parents during the recruitment and informed consent process in drug research increases the moral and instrumental value of informed consent.
引用
收藏
页码:599 / 612
页数:14
相关论文
共 53 条
  • [1] [Anonymous], ONE SIZE DOES NOT FI
  • [2] [Anonymous], PAEDIAT PERINAT DRUG
  • [3] [Anonymous], ARCH DIS CHILD FETAL
  • [4] [Anonymous], J PEDIAT HEMATOL ONC
  • [5] [Anonymous], PRACT DIABETES INT
  • [6] [Anonymous], 1978, BELM REP ETH PRINC G
  • [7] [Anonymous], 1989, UN TREAT SER
  • [8] Initial development of a questionnaire evaluating perceived benefits and barriers to pediatric clinical trials participation
    Barakat, Lamia P.
    Patterson, Chavis A.
    Mondestin, Valerie
    Chavez, Veronica
    Austin, Tahirah
    Robinson, M. Renee
    Li, Yimei
    Smith-Whitley, Kim
    Cohen, Robyn
    [J]. CONTEMPORARY CLINICAL TRIALS, 2013, 34 (02) : 218 - 226
  • [9] An approach to community consultation prior to initiating an emergency research study incorporating a waiver of informed consent
    Baren, JM
    Anicetti, JP
    Ledesma, S
    Biros, MH
    Mahabee-Gittens, M
    Lewis, RJ
    [J]. ACADEMIC EMERGENCY MEDICINE, 1999, 6 (12) : 1210 - 1215
  • [10] Barrera Maru, 2005, Palliat Support Care, V3, P191